ArticleMedicine2025
The relationship between the neutrophil to high-density lipoprotein cholesterol ratio and the risk of nonalcoholic fatty liver disease based on sex differences: A cross-sectional NHANES study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The neutrophil to high-density lipoprotein cholesterol ratio (NHR) is an emerging marker of lipid and inflammatory metabolic dysregulation, previously linked to nonalcoholic fatty liver disease (NAFLD) risk in small-scale studies. However, large-scale analyses and investigations into sex-based differences remain limited. This study aims to evaluate the association between NHR and NAFLD risk across different sexes. Using data from NHANES 2017 to 2020, this study included 6354 eligible adults. Subgroup analyses were performed to assess NHR's predictive effect on NAFLD risk across various populations. Multivariable logistic regression and restricted cubic spline (RCS) analyses were employed to explore the NHR-NAFLD association by sex. All analyses incorporated sample weighting to ensure representative findings. NHR was significantly positively associated with NAFLD risk, with prevalence increasing across higher NHR quartiles (25.92%, 34.69%, 50.25%, 61.60%; P < .001). Males exhibited significantly higher NHR levels than females (P < .001). In males, NAFLD prevalence increased with higher NHR scores, whereas it decreased in females, with significant sex differences (P < .001). Multivariable logistic regression revealed that each one-unit increase in NHR was associated with a 37.5% higher risk of NAFLD in males and a 30.1% increase in females. RCS analysis confirmed a nonlinear association in both sexes, with inflection points at approximately 5.6 for males and 6.1 for females, indicating a significant rise in risk beyond these points. Subgroup analysis showed that the predictive effect of NHR was approximately 12% higher in males (OR = 1.40) compared to females (OR = 1.28), with significant interaction effects (P < .001). NHR has predictive value for nonalcoholic fatty liver disease, and the risk of disease in males is slightly higher than in females. NHR, as a marker of lipid and inflammatory metabolism, can be utilized for the early screening and prevention of nonalcoholic fatty liver disease in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.